Banks including Goldman Sachs Group Inc and Citigroup Inc. are among 22 banks set to provide Clayton Dubilier & Rice with ...
Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling ...
Operating independently within Sanofi, Opella has resources allocated for research and development, production, and digital ...
Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity ...
Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in ...
The French government is looking at options including state-owned investment bank BPIfrance taking a stake in the consumer ...
(Reuters) - Private equity firm Clayton Dubilier & Rice (CD&R) is nearing a deal to acquire Sanofi's consumer health unit for ...
France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...
An offer from US private equity firm Clayton, Dubilier & Rice has beaten rivals, pursuing French pharmaceutical company Sanofi’s consumer healthcare division, in what is set to be the largest European ...
Sanofi to sell consumer health unit for $16.4 billion to private equity firm Clayton Dubilier & Rice in upcoming deal ...
French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health business Opella, the Le Monde newspaper said on Thursday, as PAI seeks to outbid U.S. rival ...